A Phase II, Randomized, Multicenter Study of PEGPH20 (PE

Project: Research project

Project Details

Description

A Phase II, Randomized, Multicenter Study of PEGPH20 (PEGylated Recombinant Human Hyaluronidase) Combined with nab-Paclitaxel Plus Gemcitabine Compared With nab-Paclitaxel Plus Gemcitabine in Subject with Stage IV previously untreated Pancreatic Cancer
StatusFinished
Effective start/end date5/10/1311/30/19

Funding

  • HALOZYME, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.